Evidence map›Paper›PMID 37702348›Full record

ArticleESC heart failure2023

Missed opportunities in the diagnosis of heart failure: a real-world assessment.

João Pedro Ferreira, Tiago Taveira-Gomes, Mariana Canelas-Pais, Phillip Phan, Filipa Bernardo, Karolina Andersson Sundell, Mário Almeida, Hugo Martinho, Cristina Gavina

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 7 countries.

João Pedro FerreiraDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular R&D Centre - UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal.ORCID 0000-0002-2304-6138
Tiago Taveira-GomesDepartment of Community Medicine, Information and Decision in Health, Faculty of Medicine of the University of Porto, Porto, Portugal.
Mariana Canelas-PaisDepartment of Community Medicine, Information and Decision in Health, Faculty of Medicine of the University of Porto, Porto, Portugal.
Phillip PhanAstraZeneca, Cambridge, UK.
Filipa BernardoAstraZeneca, Lisbon, Portugal.
Karolina Andersson SundellAstraZeneca, Gothenburg, Sweden.
Mário AlmeidaAstraZeneca, Lisbon, Portugal.
Hugo MartinhoAstraZeneca, Lisbon, Portugal.
Cristina GavinaDepartment of Physiology and Cardiothoracic Surgery, Cardiovascular R&D Centre - UnIC@RISE, Faculty of Medicine of the University of Porto, Porto, Portugal.
AstraZeneca (Portugal) · PTInserm · FRAstraZeneca (Netherlands) · NLAstraZeneca (United Kingdom) · GBFernando Pessoa University · PTUniversidade do Porto · PT

Funding

AstraZeneca
6 · The paper itself

Abstract

aimsHeart failure (HF) is a leading cause of hospitalization worldwide. An early HF diagnosis is key to reducing hospitalizations. We used electronic health records (EHRs) to characterize HF pathways at the primary care physician (PCP) level prior to a first HF hospitalization (hHF). This study aimed to identify missed opportunities for HF diagnosis and management at the PCP level before a first hHF. METHODS AND

resultsThis cohort study used EHRs of a large health care organization in Portugal. Patients with incident hHF between 2017 and 2020 were identified. Missed opportunities were defined by the absence of any of the following work-up in the 6 months after signs or symptoms had been recorded: lab results and electrocardiogram, natriuretic peptides, echocardiogram, referral to HF specialist, or HF medication initiation. A total of 2436 patients with a first hHF were identified. The median (interquartile range) age at the time of hospitalization was 81 (14) years, and 1361 (56%) were women. Most patients were treated with cardiovascular drugs prior or at index event. A total of 720 (30%) patients had records of HF signs or symptoms, 94% (n = 674) within 6 months prior to hHF. Among patients with recorded HF signs or symptoms, 410 (57%) had clinical management considered adequate before signs and symptoms were recorded. Of the 310 remaining patients, 155 (50%) had a follow-up that was considered inadequate.

conclusionsRelatively few patients with a first hHF had primary care records of signs or symptoms prior to admission. Of these, nearly half had inadequate management considering diagnosis and treatment. These data suggest the need to improve PCP HF awareness.

Indexed as

Heart FailureCohort StudiesEarly DiagnosisFemaleHospitalizationHumansMaleTreatment OutcomeDisease managementElectronic health recordsHeart failureMissed opportunitiesPrimary care

Identifiers

PMID37702348
PMCPMC10682848
OpenAlexW4386704420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.